hero section gradient
17 handpicked stocks

Skills Over Scrolls: The Trade School Boom

Mike Rowe's proposal to redirect federal grants from elite universities to trade schools could reshape education funding in America. This carefully selected group of stocks includes companies that stand to benefit if billions flow into vocational training—from tool manufacturers to trade schools themselves.

Author avatar

Han Tan | Market Analyst

Published on July 1

Your Basket's Financial Footprint

This basket's total market capitalisation is $1.00T, and it is heavily anchored by a few very large-cap holdings.

Key Takeaways for Investors:
  • Large-cap dominance generally implies lower volatility and closer tracking of established market performance.
  • Use this as a core, diversified holding rather than a speculative or high-growth allocation.
  • Likely to deliver steady, long-term value rather than explosive short-term gains.
Total Market Cap
  • FAST: $49.73B

  • SWK: $10.97B

  • LINC: $730.39M

  • Other

About This Group of Stocks

1

Our Expert Thinking

These companies are positioned at the crossroads of policy and industry need. If federal funding shifts toward vocational education, billions could flow into an ecosystem that trains and employs skilled workers—potentially creating significant growth opportunities across multiple sectors.

2

What You Need to Know

This group offers exposure to America's skilled labor gap solution. It spans industries from industrial tool manufacturers and building supply distributors to technical colleges and specialized staffing firms—capturing the entire value chain from classroom to job site.

3

Why These Stocks

Each company was selected based on its potential to directly benefit from increased vocational training investment. These businesses either supply the tools and materials needed for training, provide the education itself, or employ graduates with in-demand skills.

Why You'll Want to Watch These Stocks

🔧

America's $1.2 Trillion Skills Gap

The US faces a massive shortage of skilled tradespeople that's costing the economy billions. These companies provide the solutions to close this gap and could see substantial growth as policy shifts toward vocational training.

💰

Follow the Federal Funding

If Mike Rowe's proposal succeeds, billions in education grants could redirect from universities to trade schools. These companies stand at the receiving end of that potential funding waterfall.

🎓

The Anti-College Play

With student debt at record highs and many questioning the value of traditional degrees, these companies offer exposure to the growing alternative: practical skills education that leads directly to well-paying jobs.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions